COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA

• 收藏
• 分享

专利权人:

ABBOTT BIOTHERAPEUTICS CORP.

发明人:

AFAR, DANIEL

申请号：

NZ57497907

公开号：

NZ574979A

申请日:

2007.08.07

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

The use of HuLuc63 that is a humanised antibody having a heavy chain variable region corresponding to SEQ ID NO: 5 and a light chain variable region corresponding to SEQ ID NO: 6 for treating multiple myeloma. The HuLuc63 is administered sequentially or co-administered with dexamethasone, or dexamethasone and thalidomide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/